Top

International Journal of Colorectal Disease

Published in:

01-06-2014 | Original Article

Predictive factors for perioperative blood transfusions in laparoscopic colorectal surgery

Authors: Yasmin Abu-Ghanem, Hussein Mahajna, Ronen Ghinea, Ian White, Roy Inbar, Shmuel Avital

Published in: International Journal of Colorectal Disease | Issue 6/2014

Abstract

Background

Allogeneic perioperative blood transfusion (PBT) has been associated with higher rates of postoperative complications in patients undergoing colorectal surgery and increased tumor recurrence in cancer patients. Our aim is to evaluate possible predictive factors for PBT, specifically, in patients undergoing laparoscopic colorectal surgery, in order to identify patients who could benefit from alternatives to allogenic PBT such as erythropoietin administration, autologous blood transfusion, and possibly preoperative blood transfusion.

Methods

Five hundred patients who underwent laparoscopic colorectal surgery between the years 2003 and 2011 were reviewed. Patient demographics and clinicopathologic variables were collected prospectively. Other clinical data were collected directly from the computerized records of the in-hospital blood bank. PBT was defined as transfusion of allogenic red blood cells during the day of operation or within the postoperative hospitalization. The associations between PBT and patient variables were assessed by univariate and multivariate analyses.

Results

Of the 500 patients, 134 patients (26.8 %) received PBT. Multivariate analysis revealed four preoperative variables as significant risk factors for PBT: preoperative hemoglobin (P = 0.001), lower rectal surgery (P = 0.009), Charlson comorbidity score (P = 0.001), and malignancy (P = 0.024).

Conclusions

Preoperative Charlson score, hemoglobin level, carcinoma, and lower rectum pathologies were found to be independent risk factors for PBT in patients undergoing laparoscopic colorectal surgery. Evaluation of these risk factors prior to surgery may be helpful in selecting the patients who could benefit from possible alternatives to perioperative allogeneic blood transfusion and help constitute guidelines for a more responsible use of these alternatives.

Jagoditsch M, Pozgainer P, Klingler A, Tschmelitsch J (2006) Impact of blood transfusions on recurrence and survival after rectal cancer surgery. Dis Colon Rectum 49(8):1116–1130PubMedCrossRef

Benoist S, Panis Y, Pannegeon V, Alves A, Valleur P (2001) Predictive factors for perioperative blood transfusions in rectal resection for cancer: a multivariate analysis of a group of 212 patients. Surgery 129(4):433–439PubMedCrossRef

Amato A, Pescatori M (2011) Perioperative blood transfusions and recurrence of colorectal cancer (review) no. 2

Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ (1996) The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 334(26):1685–1690PubMedCrossRef

Ghinea R, Greenberg I, White E, Sacham-Shmueli H, Mahagna, S. Avital (2013) Perioperative blood transfusion in cancer patients undergoing laparoscopic colorectal resection: risk factors and impact on survival. Tech Coloproctol

Tartter PI (1988) Blood transfusion and infectious complications following colorectal cancer surgery. Brit J Surg 75(8):789–792PubMedCrossRef

Wobbes T, Bemelmans BL, Kuypers JH, Beerthuizen GI, Theeuwes AG (1990) Risk of postoperative septic complications after abdominal surgical treatment in relation to perioperative blood transfusion. Surg Gynecol Obstet 171(1):59–62PubMed

Edna TH, Bjerkeset T (1998) Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer. Dis Colon Rectum 41(4):451–459PubMedCrossRef

Blumberg N, Agarwal MM, Chuang C (1985) Relation between recurrence of cancer of the colon and blood transfusion. Br Med J (Clin Res Ed) 290(6474):1037–1039CrossRef

10.

Burrows L, Tartter P (1982) Effect of blood transfusions on colonic malignancy recurrent rate. Lancet 2(8299):662PubMedCrossRef

11.

Amato AC, Pescatori M (1998) Effect of perioperative blood transfusions on recurrence of colorectal cancer: meta-analysis stratified on risk factors. Dis Colon Rectum 41(5):570–585PubMedCrossRef

12.

Linder BJ, Frank I, Cheville JC, Tollefson MK, Thompson RH, Tarrell RF, Thapa P, Boorjian SA (2013) The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 63(5):839–845PubMedCrossRef

13.

Braga M, Vignali A, Gianotti L, Zuliani W, Radaelli G, Gruarin P, Dellabona P, Di Carlo V (2002) Laparoscopic versus open colorectal surgery: a randomized trial on short-term outcome. Ann Surg 236(6):759–766, discussion 767PubMedCentralPubMedCrossRef

14.

Heiss MM, Mempel W, Delanoff C, Jauch KW, Gabka C, Mempel M, Dieterich HJ, Eissner HJ, Schildberg FW (1994) Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol Off J Am Soc Clin Oncol 12(9):1859–1867

15.

Gohel MS, Bulbulia RA, Slim FJ, Poskitt KR, Whyman MR (2005) How to approach major surgery where patients refuse blood transfusion (including Jehovah’s Witnesses). Ann R Coll Surg Engl 87(1):3–14PubMedCentralPubMedCrossRef

16.

Miki C, Hiro J, Ojima E, Inoue Y, Mohri Y, Kusunoki M (2006) Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer. Clin Oncol 18(1):60–66

17.

Kim J, Konyalian V, Huynh R, Mittal R, Stamos M, Kumar R (2007) Identification of predictive factors for perioperative blood transfusion in colorectal resection patients. Int J Colorectal Dis 22(12):1493–1497

18.

Tang R, Wang JY, Chien CR, Chen JS, Lin SE, Fan HA (1993) The association between perioperative blood transfusion and survival of patients with colorectal cancer. Cancer 72(2):341–348PubMedCrossRef

19.

Sabalić S, Kovacević D, Glavić Z, Buković D, Despot A, Fajdić J, Lukac J, Seso I (2006) The immunomodulation effect of allogenic blood transfusion in colorectal cancer—a new approach. Coll Antropol 30(4):885–893PubMed

20.

Gascón P, Zoumbos NC, Young NS (1984) Immunologic abnormalities in patients receiving multiple blood transfusions. Ann Intern Med 100(2):173–177PubMedCrossRef

21.

Ghio M, Contini P, Mazzei C, Brenci S, Barberis G, Filaci G, Indiveri F, Puppo F (1999) Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions. Blood 93(5):1770–1777PubMed

22.

Kaplan J, Sarnaik S, Gitlin J, Lusher J (1984) Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 64(1):308–310PubMed

23.

Opelz G, Terasaki PI (1974) Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions. Lancet 2(7882):696–698PubMedCrossRef

24.

Edna TH, Bjerkeset T (1992) Association between blood transfusion and infection in injured patients. J Trauma 33(5):659–661PubMedCrossRef

25.

Jensen LS, Andersen AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G, Mortensen J, Møller-Nielsen C, Hanberg-Sørensen F, Hokland M (1992) Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 79(6):513–516PubMedCrossRef

26.

Bernard AC, Davenport DL, Chang PK, Vaughan TB, Zwischenberger JB (2009) Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg 208(5):931–937, 937.e1–2; discussion 938–9PubMedCrossRef

27.

Torchia MG, Danzinger RG (2000) Perioperative blood transfusion and albumin administration are independent risk factors for the development of postoperative infections after colorectal surgery. Can J Surg J Can Chir 43(3):212–216

28.

Moore FA, Moore EE, Sauaia A (1997) Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surgery (Chicago, Ill: 1960) 132(6):620–624, discussion 624–5CrossRef

29.

Malone DL, Dunne J, Tracy JK, Putnam AT, Scalea TM, Napolitano LM (2003) Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 54(5):898–905, discussion 905–7PubMedCrossRef

30.

Amato A, Pescatori M (2006) Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 1: CD005033

31.

Busch OR, Hop WC, Marquet RL, Jeekel J (1994) Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship. Ann Surg 220(6):791–797PubMedCentralPubMedCrossRef

32.

Kosmadakis N, Messaris E, Maris A, Katsaragakis S, Leandros E, Konstadoulakis MM, Androulakis G (2003) Perioperative erythropoietin administration in patients with gastrointestinal tract cancer: prospective randomized double-blind study. Ann Surg 237(3):417–421PubMedCentralPubMed

33.

Karkouti K, McCluskey SA, Evans L, Mahomed N, Ghannam M, Davey R (2005) Erythropoietin is an effective clinical modality for reducing RBC transfusion in joint surgery. Can J Anaesth J Can Anesth 52(4):362–368CrossRef

34.

Kettelhack C, Hönes C, Messinger D, Schlag PM (1998) Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma. Bri J Surg 85(1):63–67

35.

Nursal TZ, Hamaloğlu E (2006) The effect of preoperative blood transfusion on morbidity and survival in colorectal malignancy. Turk J Gastroenterol Off J Turk Soc Gastroenterol 17(4):283–287

36.

Carson JL (1998) Perioperative blood transfusion and postoperative mortality. JAMA 279(3):199PubMed

37.

Amar D, Grant FM, Zhang H, Boland PJ, Leung DH, Healey JA (2003) Antifibrinolytic therapy and perioperative blood loss in cancer patients undergoing major orthopedic surgery. Anesthesiology 98(2):337–342PubMed

38.

Gonçalves I, Linhares M, Bordin J, Matos D (2009) Artigo original/Original article. Risk factors for indications of among patients undergoing surgical treatment for colorectal adenocarcinoma. Arq Gastroenterol 3:190–193

39.

Frank SM, Savage WJ, Rothschild JA, Rivers RJ, Ness PM, Paul SL, Ulatowski JA (2012) Variability in blood and blood component utilization as assessed by an anesthesia information management system. Anesthesiology 117(1):99–106PubMed

Title: Predictive factors for perioperative blood transfusions in laparoscopic colorectal surgery
Authors: Yasmin Abu-Ghanem
Hussein Mahajna
Ronen Ghinea
Ian White
Roy Inbar
Shmuel Avital
Publication date: 01-06-2014
Publisher: Springer Berlin Heidelberg
Published in: International Journal of Colorectal Disease / Issue 6/2014
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-014-1854-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Predictive factors for perioperative blood transfusions in laparoscopic colorectal surgery

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2014

Therapy of complicated Crohn’s disease during pregnancy—an interdisciplinary challenge

Influence of CD68+ macrophages and neutrophils on anastomotic healing following laparoscopic sigmoid resection due to diverticulitis

Intestinal permeability, systemic endotoxemia, and bacterial translocation after open or laparoscopic resection: the critical role of bowel preparation

The outcome of liver resection and lymphadenectomy for hilar lymph node involvement in colorectal cancer liver metastases

Expression analysis of heat shock protein 90 (HSP90) and Her2 in colon carcinoma

Can hyperthermic intraperitoneal chemotherapy efficiency be improved by blocking the DNA repair factor COP9 signalosome?